Loncar Cancer Immunotherapy ETF’s (CNCR) Moving Averages Convergence Divergence (MACD) indicator is -0.43, suggesting Loncar Cancer Immunotherapy ETF is a Buy.
Loncar Cancer Immunotherapy ETF’s (CNCR) 20-Day exponential moving average is 14.32, making it a Sell.
Loncar Cancer Immunotherapy ETF’s (CNCR) 50-Day exponential moving average is 14.66, making it a Sell.